Ligand Pharmaceuticals, Inc. (LGND)
183.98
-2.34
(-1.26%)
USD |
NASDAQ |
Feb 20, 16:00
183.59
-0.39
(-0.21%)
After-Hours: 20:00
Ligand Pharmaceuticals Total Assets (Quarterly) : 1.477B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | -- |
| ADMA Biologics, Inc. | 568.69M |
| Johnson & Johnson | 199.21B |
| Elanco Animal Health, Inc. | 13.55B |
| Ionis Pharmaceuticals, Inc. | 3.033B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 526.60M |
| Shareholders Equity (Quarterly) | 950.17M |
| Debt to Equity Ratio | 0.4746 |
| Current Ratio | 24.69 |
| Net Debt Paydown Yield | -2.55% |